Preventing thrombosis in a COVID‐19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation

BACKGROUND: Preventing thrombosis in extracorporeal membrane oxygenation (ECMO) can be life‐saving in cases of coronavirus disease (COVID‐19); however, circuit thrombosis is a complication. This report describes a COVID‐19 patient treated with nafamostat and heparin to prevent circuit thrombosis dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Shunichi, Akashi, Yoshihiro J., Takita, Mumon, Yoshida, Hideki, Morikawa, Daiki, Ishibashi, Yuki, Higuma, Takumi, Fujitani, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537502/
https://www.ncbi.nlm.nih.gov/pubmed/33042560
http://dx.doi.org/10.1002/ams2.585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537502/
https://www.ncbi.nlm.nih.gov/pubmed/33042560
http://dx.doi.org/10.1002/ams2.585

Ejemplares similares